XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period Of Adoption, Adjustment
Various Stock Compensation Plans And Agreements
Stock Repurchase Plan
Common Stock
Common Stock
Various Stock Compensation Plans And Agreements
Common Stock
Stock Repurchase Plan
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period Of Adoption, Adjustment
Treasury Stock
Treasury Stock
Various Stock Compensation Plans And Agreements
AOCI, Net of Tax
Beginning balance (in shares) at Dec. 31, 2021         141,907,954                
Beginning balance at Dec. 31, 2021 $ 5,837,218             $ 1,893,725 $ 4,683,659   $ (649,785)   $ (90,381)
Increase (Decrease) in Stockholders' Equity                          
Net income 791,320               791,320        
Other comprehensive loss (709,651)                       (709,651)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         640,053                
Issuance of common stock pursuant to various stock compensation plans and agreements 32,836             32,836          
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (244,978) (1,385,517)            
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     $ (18,983) $ (99,990)               $ (18,983)  
Cash dividends on common stock (172,082)               (172,082)        
Ending balance (in shares) at Sep. 30, 2022         140,917,512                
Ending balance at Sep. 30, 2022 5,660,668             1,926,561 5,302,897   (768,758)   (800,032)
Beginning balance (in shares) at Jun. 30, 2022         140,917,389                
Beginning balance at Jun. 30, 2022 5,609,482             1,914,232 5,064,650   (768,752)   (600,648)
Increase (Decrease) in Stockholders' Equity                          
Net income 295,339               295,339        
Other comprehensive loss (199,384)                       (199,384)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         206                
Issuance of common stock pursuant to various stock compensation plans and agreements 12,329             12,329          
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (83)              
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     (6)                 (6)  
Cash dividends on common stock (57,092)               (57,092)        
Ending balance (in shares) at Sep. 30, 2022         140,917,512                
Ending balance at Sep. 30, 2022 5,660,668             1,926,561 5,302,897   (768,758)   (800,032)
Beginning balance (in shares) at Dec. 31, 2022         140,947,846                
Beginning balance at Dec. 31, 2022 5,984,612             1,936,557 5,582,546   (768,862)   (765,629)
Beginning balance (Accounting Standards Update 2022-02) at Dec. 31, 2022 [1]   $ (4,262)               $ (4,262)      
Increase (Decrease) in Stockholders' Equity                          
Net income 922,208               922,208        
Other comprehensive loss (109,748)                       (109,748)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         857,501                
Issuance of common stock pursuant to various stock compensation plans and agreements 32,851             32,851          
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (319,398)              
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     (23,214)                 (23,214)  
Cash dividends on common stock (205,741)               (205,741)        
Ending balance (in shares) at Sep. 30, 2023         141,485,949                
Ending balance at Sep. 30, 2023 6,596,706             1,969,408 6,294,751   (792,076)   (875,377)
Beginning balance (in shares) at Jun. 30, 2023         141,483,668                
Beginning balance at Jun. 30, 2023 6,461,697             1,959,784 6,075,735   (791,890)   (781,932)
Increase (Decrease) in Stockholders' Equity                          
Net income 287,738               287,738        
Other comprehensive loss (93,445)                       (93,445)
Issuance of common stock pursuant to various stock compensation plans and agreements (in shares)         5,682                
Issuance of common stock pursuant to various stock compensation plans and agreements 9,624             9,624          
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements (in shares)           (3,401)              
Repurchase of common stock pursuant to the Stock Repurchase Program/various stock compensation plans and agreements     $ (186)                 $ (186)  
Cash dividends on common stock (68,722)               (68,722)        
Ending balance (in shares) at Sep. 30, 2023         141,485,949                
Ending balance at Sep. 30, 2023 $ 6,596,706             $ 1,969,408 $ 6,294,751   $ (792,076)   $ (875,377)
[1] Represents the change in the Company’s allowance for loan losses as a result of the adoption of Accounting Standards Update (“ASU”) 2022-02, Financial Instruments - Credit Losses (Topic 326): Troubled Debt Restructurings and the Vintage Disclosures on January 1, 2023. Refer to Note 2 — Current Accounting Developments and Summary of Significant Accounting Policies in this Form 10-Q for additional information.